449 related articles for article (PubMed ID: 33966960)
1. IABS/CEPI platform technology webinar: Is it possible to reduce the vaccine development time?
Vandeputte J; Saville M; Cavaleri M; Friede M; Hacker A; Mueller SO; Rizzi R; Smith D; Thirstrup S; Wagner R; Baay M; Neels P
Biologicals; 2021 Jun; 71():55-60. PubMed ID: 33966960
[TBL] [Abstract][Full Text] [Related]
2. Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development.
Ita K
Arch Med Res; 2021 Jan; 52(1):15-24. PubMed ID: 32950264
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 vaccine development during pandemic: gap analysis, opportunities, and impact on future emerging infectious disease development strategies.
Rele S
Hum Vaccin Immunother; 2021 Apr; 17(4):1122-1127. PubMed ID: 32993453
[TBL] [Abstract][Full Text] [Related]
4. Transforming vaccine development.
Black S; Bloom DE; Kaslow DC; Pecetta S; Rappuoli R
Semin Immunol; 2020 Aug; 50():101413. PubMed ID: 33127296
[TBL] [Abstract][Full Text] [Related]
5. Vaccine development for emerging infectious diseases.
Excler JL; Saville M; Berkley S; Kim JH
Nat Med; 2021 Apr; 27(4):591-600. PubMed ID: 33846611
[TBL] [Abstract][Full Text] [Related]
6. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
[TBL] [Abstract][Full Text] [Related]
7. Self-amplifying RNA vaccines for infectious diseases.
Bloom K; van den Berg F; Arbuthnot P
Gene Ther; 2021 Apr; 28(3-4):117-129. PubMed ID: 33093657
[TBL] [Abstract][Full Text] [Related]
8. Killed whole-genome reduced-bacteria surface-expressed coronavirus fusion peptide vaccines protect against disease in a porcine model.
Maeda DLNF; Tian D; Yu H; Dar N; Rajasekaran V; Meng S; Mahsoub HM; Sooryanarain H; Wang B; Heffron CL; Hassebroek A; LeRoith T; Meng XJ; Zeichner SL
Proc Natl Acad Sci U S A; 2021 May; 118(18):. PubMed ID: 33858942
[TBL] [Abstract][Full Text] [Related]
9. Coronavirus Disease 2019 Vaccine Development: An Overview.
Sumirtanurdin R; Barliana MI
Viral Immunol; 2021 Apr; 34(3):134-144. PubMed ID: 32985963
[TBL] [Abstract][Full Text] [Related]
10. Vaccine against SARS-CoV-2 in previously infected health care workers.
Parisi SG
EBioMedicine; 2021 Sep; 71():103556. PubMed ID: 34454402
[No Abstract] [Full Text] [Related]
11. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M
Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 vaccines for patients with haematological conditions.
Sun C; Pleyer C; Wiestner A
Lancet Haematol; 2021 May; 8(5):e312-e314. PubMed ID: 33811822
[No Abstract] [Full Text] [Related]
13. COVID-19 vaccine development: What lessons can we learn from TB?
Safar HA; Mustafa AS; McHugh TD
Ann Clin Microbiol Antimicrob; 2020 Nov; 19(1):56. PubMed ID: 33256750
[TBL] [Abstract][Full Text] [Related]
14. Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need.
Jin P; Li J; Pan H; Wu Y; Zhu F
Signal Transduct Target Ther; 2021 Feb; 6(1):48. PubMed ID: 33531462
[TBL] [Abstract][Full Text] [Related]
15. One Shot Wonder: A Vaccine Against All Coronaviruses.
Mertz L
IEEE Pulse; 2020; 11(6):2-5. PubMed ID: 33315546
[TBL] [Abstract][Full Text] [Related]
16. Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.
Behr MA; Divangahi M; Schurr E
J Infect Dis; 2021 Feb; 223(2):189-191. PubMed ID: 33535239
[TBL] [Abstract][Full Text] [Related]
17. Editorial: Challenges in Vaccinology.
Lavelle EC; Carsetti R; Pickl WF; Wiedermann U
Front Immunol; 2020; 11():632537. PubMed ID: 33391292
[No Abstract] [Full Text] [Related]
18. Efforts towards a COVID-19 vaccine.
Brüssow H
Environ Microbiol; 2020 Oct; 22(10):4071-4084. PubMed ID: 32893468
[TBL] [Abstract][Full Text] [Related]
19. [Vaccination immunology in SARS-CoV-2].
Helweg-Larsen J; Benfield T
Ugeskr Laeger; 2021 Mar; 183(11):. PubMed ID: 33734074
[TBL] [Abstract][Full Text] [Related]
20. How nano can fight the virus.
Ball P
Nat Mater; 2021 Feb; 20(2):126. PubMed ID: 33504984
[No Abstract] [Full Text] [Related]
[Next] [New Search]
